Table 1.
Baseline characteristics of enrolled PAD patients.
| Variables | Total (n = 149) | Endovascular Revascularization (n = 100) | Bypass Surgery (n = 49) | p Value |
|---|---|---|---|---|
| Age, years | 70.3 ± 9.7 | 70.1 ± 9.9 | 70.7 ± 9.3 | 0.704 |
| Male, % | 125 (84%) | 82 (82%) | 43 (88%) | 0.258 |
| Systolic BP, mmHg | 125.1 ± 18.2 | 124.4 ± 19.8 | 126.7 ± 14.6 | 0.424 |
| Diastolic BP, mmHg | 77.8 ± 10.6 | 77.6 ± 10.6 | 78.2 ± 10.6 | 0.749 |
| Heart rate, bpm | 80.4 ± 13.0 | 80.6 ± 13.6 | 80.2 ± 11.9 | 0.870 |
| Total cholesterol | 163.8 ± 48.2 | 162.4 ± 53.7 | 166.6 ± 34.5 | 0.576 |
| LDL, mg/dL | 103.4 ± 47.5 | 105.6 ± 47.1 | 98.9 ± 48.9 | 0.568 |
| HDL, mg/dL | 40.6 ± 28.8 | 41.6 ± 33.9 | 38.5 ± 14.1 | 0.572 |
| C-reactive protein, mg/L | 4.2 ± 16.1 | 3.85 ± 15.4 | 0.96 ± 2.65 | 0.350 |
| Ankle brachial index | 0.75 ± 0.24 | 0.77 ± 0.24 | 0.70 ± 0.24 | 0.181 |
| Hypertension, % | 95 (64%) | 63 (63%) | 32 (65%) | 0.465 |
| Diabetes, % | 58 (39%) | 38 (38%) | 20 (41%) | 0.438 |
| Dyslipidemia, % | 92 (62%) | 62 (62%) | 30 (61%) | 0.533 |
| Current smoker, % | 48 (32%) | 33 (33%) | 15 (31%) | 0.461 |
| Ex-smoker, % | 21 (14%) | 11 (11%) | 10 (20%) | 0.099 |
| Aspirin, % | 87 (58%) | 60 (60%) | 27 (55%) | 0.329 |
| Clopidogrel, % | 29 (20%) | 20 (20%) | 9 (18%) | 0.500 |
| Cilostazol, % | 10 (7%) | 8 (8%) | 2 (4%) | 0.302 |
| BP medication, % | 88 (59%) | 59 (59%) | 29 (59%) | 0.782 |
| Statin, % | 62 (42%) | 48 (48%) | 14 (29%) | 0.024 |
| Location | ||||
| Aorto-iliac | 48 (32.2%) | 46 (46%) | 2 (4%) | <0.001 |
| Femoropopliteal | 101 (67.8%) | 54 (54%) | 47 (96%) | <0.001 |
Values are expressed as means ± SD. PAD: peripheral artery disease; BP: blood pressure; LDL: low density lipoprotein; HDL: high density lipoprotein.